Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Pfizer Healthcare India Private Limited | Anakapalli, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyOct 18, 2022 · 7 inspections, 1 with FDA action |
| PPD Development, L.P. | Middleton, WI, United States | Tests it | Problems found, fixed voluntarilySep 25, 2025 · 6 inspections |
Recalls
- Sep 24, 2013 · Class II · Hospira Inc.
Presence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.
Lots: Lot #: 28-104-DK*, Exp 10/01/2014 (* lot number may be proceeded with an 01)
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Metoclopramide: every company that makes it
- Form
- injection, solution, intramuscular; intravenous
- Strength
- 5 mg per 1 mL
- Approval
- ANDA ANDA073118
- On the market since
- Feb 2, 2006
- Package NDCs
0409-3414-010409-3414-110409-3414-180409-3414-21- Official label
- DailyMed (National Library of Medicine), updated Apr 14, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?